Axl Inhibitors

The Axl inhibitors class comprises small molecules designed to selectively target Axl, a receptor tyrosine kinase implicated in various cellular processes, including proliferation, survival, and migration. These inhibitors interfere with Axl autophosphorylation and downstream signaling pathways, disrupting cellular functions associated with Axl dysregulation. Notable members of this class include BGB324 (R428), TP-0903, and SGI-7079, each exerting inhibitory effects on Axl kinase activity. BGB324 (R428), a representative compound, binds to the kinase domain of Axl, inhibiting its autophosphorylation and subsequent signaling. This disruption impacts cellular processes, providing researchers with a tool to explore Axl's role in diseases like cancer. Similarly, TP-0903 and SGI-7079 target Axl and related kinases, influencing signaling cascades and cellular dynamics associated with Axl dysregulation. Other members of the Axl inhibitors class, including R428 Hydrochloride, Bemcentinib (R428, BGB324) Mesylate, UNC2025, and UNC21461, share similar mechanisms of action. They interfere with Axl kinase activity, providing researchers with a comprehensive toolkit to dissect the specific contributions of Axl to cellular processes and explore implications in diseases where Axl dysregulation plays a crucial role. These Axl inhibitors, including NPS-1034, BMS-777607, R428 Dihydrochloride, UNC2025 Hydrochloride, UNC3230, and UNC21461, extend the repertoire of tools available to researchers.